HYEX Pengajuan SEC - Healthy Extracts Inc.- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

CIK

1630176

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Healthy Extracts Inc.

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

August 13, 2025	10-Q	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 HEALTHY EXTRACTS INC. (Exa
July 24, 2025	EX-10.1	Membership Interest Purchase Agreement with Gummy USA LLC dated July 19, 2025 MEMBERSHIP INTEREST PURCHASE AGREEMENT This Membership Interest Purchase Agreement (this “Agreement”) is entered into on July 19, 2025 (the “Effective Date”) by and among Healthy Extracts Inc.
July 24, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2025 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55572 (Commission File Number) 47-
May 13, 2025	10-Q	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 HEALTHY EXTRACTS INC. (Ex
April 22, 2025	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extracts Inc.
April 1, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extracts Inc. (E
April 1, 2025	NT 10-K	UNITED STATES Renewable Innovations 10-Q Late Notice 2.28.23 (02127246).DOCX UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-5572 Washington, D.C. 20549 CUSIP No: 42227D 20 9 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-CEN ¨ Form N-CSR For Period Ended: December 31, 2024 ¨ Transition report on Form 10-K ¨ Transition
November 12, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 HEALTHY
August 14, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extr
May 20, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Ext
May 15, 2024	NT 10-Q	UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-5572 Washington, D.
May 10, 2024	EX-10.2	Second Amendment to 10% OID Promissory Note SECOND AMENDMENT TO 10% OID PROMISSORY NOTE This Second Amendment to the 10% OID Promissory Note (this “Amendment”) is entered into on May 3, 2024 (the “Execution Date”) and effective as of April 24, 2024 (the “Effective Date”) by and between Healthy Extracts, Inc.
May 10, 2024	RW	May 10, 2024 May 10, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.
May 10, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2024 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47-2
May 10, 2024	EX-10.1	Second Amendment to 10% OID Promissory Note SECOND AMENDMENT TO 10% OID PROMISSORY NOTE This Second Amendment to the 10% OID Promissory Note (this “Amendment”) is entered into on April 23rd, 2024 (the “Execution Date”) and effective as of April 24, 2024 (the “Effective Date”) by and between Healthy Extracts, Inc.
April 24, 2024	8-K	Termination of a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 18, 2024 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 4
April 1, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extracts Inc. (E
December 29, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2023 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number
December 29, 2023	EX-3.1	Certificate of Amendment of Articles of Incorporation filed December 19, 2023 HE ArtAmend re Split (01956118-5).DOCX CERTIFICATE OF AMENDMENT to ARTICLES OF INCORPORATION of HEALTHY EXTRACTS INC. The undersigned hereby certifies: 1. The name of the Corporation is Healthy Extracts Inc. 2. The articles have been amended as follows: Article 3 is amended and restated as follows: “Article 3, Authorized Stock: The Corporation has the authority to issue Fifty Million (50,000,000)
November 22, 2023	S-1/A	As filed with the Securities and Exchange Commission on November 22, 2023 As filed with the Securities and Exchange Commission on November 22, 2023 Registration No.
November 14, 2023	10-Q	SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extracts Inc.
November 8, 2023	EX-10.2	First Amendment to 10% OID Promissory Note FIRST AMENDMENT TO 10% OID PROMISSORY NOTE This First Amendment to the 10% OID Promissory Note (this “Amendment”) is entered into on October 31, 2023 (the “Execution Date”) and effective as of October 24, 2023 (the “Effective Date”) by and between Healthy Extracts, Inc.
November 8, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2023 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other jurisdiction of incorporation) (Commission File Number) (I
November 8, 2023	EX-10.1	First Amendment to 10% OID Promissory Note FIRST AMENDMENT TO 10% OID PROMISSORY NOTE This First Amendment to the 10% OID Promissory Note (this “Amendment”) is entered into on October 31, 2023 (the “Execution Date”) and effective as of October 23, 2023 (the “Effective Date”) by and between Healthy Extracts, Inc.
October 24, 2023	S-1/A	As filed with the Securities and Exchange Commission on October 24, 2023 As filed with the Securities and Exchange Commission on October 24, 2023 Registration No.
October 6, 2023	S-1/A	As filed with the Securities and Exchange Commission on October 6, 2023 As filed with the Securities and Exchange Commission on October 6, 2023 Registration No.
September 14, 2023	S-1/A	As filed with the Securities and Exchange Commission on September 14, 2023 As filed with the Securities and Exchange Commission on September 14, 2023 Registration No.
September 14, 2023	EX-10.1	Supply Agreement with H&AD S.r.L. dated January 1, 2019, as amended SUPPLY AGREEMENT This SUPPLY AGREEMENT (hereinafter the "Agreement"), is made and entered into this 1st day of January 2019 ("Effective Date"), as follows between 1)H&AD S.
September 14, 2023	EX-10.3	Independent Contractor Agreement by and between the Company and Kevin “Duke” Pitts, dated October 1, 2019 Independent Contractor Agreement This Agreement is made between BergaMet NA LLC ("Client") with a principal place of business at 6445 South Tenaya Way Suite 110B, Las Vegas, NV 89113 and Kevin Pitts ("Contractor"), with a principal place of business at 3664 Christy Ridge Rd, Sedalia, CO 80135.
September 14, 2023	EX-10.7	Licensing Agreement with Gelteq Ptd Ltd. Key Terms – Private Label Agreement BETWEEN 1.Gelteq Pty Ltd (ACN 619 501 254) of c/o Level 7, 616-616 St Kilda Road, Melbourne, VIC 3004, Australia (Gelteq); and 2.The Purchaser as set out in Schedule below (Purchaser). No. Item Details 1. Commencement Date 07/01/2021 2. Gelteq Details Entity Gelteq Pty Ltd Company Number ACN 619 501 254 Contact Person Simon Szewach Address c/o Level 7, 616-616 S
September 7, 2023	EX-10.1	Line of Credit Promissory Note dated September 1, 2023 HEALTHY EXTRACTS INC. LINE OF CREDIT PROMISSORY NOTE Up to $82,500.00 September 1, 2023 FOR VALUE RECEIVED, Healthy Extracts Inc., a Nevada corporation, its assigns and successors (the “Company”), hereby promises to pay to Jay Decker, or his successors or assigns (the “Holder”), in immediately available funds, the total principal sum of up to Eighty Two Thousand Five Hundred Dollars ($82,500.00) (
September 7, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2023 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other jurisdiction of incorporation) (Commission
September 5, 2023	DEF 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 HE Def14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨Preliminary Information Statement ¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) xDefinitive Information Statement HEALTHY EXTRACTS INC. (Name o
August 28, 2023	EX-3.2	Certificate of Amendment of Articles of Incorporation
August 28, 2023	S-1/A	As filed with the Securities and Exchange Commission on August 25, 2023 As filed with the Securities and Exchange Commission on August 25, 2023 Registration No.
August 28, 2023	EX-3.1	Articles of Incorporation of Grey Cloak Tech Inc.
August 24, 2023	PRE 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: xPreliminary Information Statement ¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) ¨Definitive Information Statement HEALTHY EXTRACTS INC. (Name of Registra
August 14, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extr
August 4, 2023	EX-10.1	Supply Agreement with H&AD S.r.L. dated January 1, 2019, as amended Amendment to Supply Agreement (00898762).DOCX SUPPLY AGREEMENT This SUPPLY AGREEMENT (hereinafter the "Agreement"), is made and entered into this 1st day of January 2019 ("Effective Date"), as follows between 1)H&AD S.r.L. (hereinafter "Supplier"). a limited company incorporated under the laws of Italy, with registered offices located at C/da Chiusi (Industrial Zone) snc, 89032 Bianco (R.C.), Cala
August 4, 2023	S-1/A	As filed with the Securities and Exchange Commission on July [•], 2023 As filed with the Securities and Exchange Commission on July [•], 2023 Registration No.
August 4, 2023	EX-10.7	Licensing Agreement with Gelteq Ptd Ltd. HE Gelteq License (Word Version for S-1) (02164249).DOCX Key Terms – Private Label Agreement BETWEEN 1.Gelteq Pty Ltd (ACN 619 501 254) of c/o Level 7, 616-616 St Kilda Road, Melbourne, VIC 3004, Australia (Gelteq); and 2.The Purchaser as set out in Schedule below (Purchaser). No. Item Details 1. Commencement Date 07/01/2021 2. Gelteq Details Entity Gelteq Pty Ltd Company Number ACN 619 501 254 Co
June 12, 2023	S-1/A	As filed with the Securities and Exchange Commission on June 12, 2023 As filed with the Securities and Exchange Commission on June 12, 2023 Registration No.
May 15, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Ext
April 11, 2023	S-1/A	As filed with the Securities and Exchange Commission on April 11, 2023 As filed with the Securities and Exchange Commission on April 11, 2023 Registration No.
April 11, 2023	EX-10.9	Lease Agreement for warehouse and distribution facility dated January 20, 2022 Microsoft Word - Healthy Extracts Inc. (7375 #125) Lease Agreement 01.20.22 LEASE AGREEMENT (Net) THIS LEASE AGREEMENT ("Lease") is made between Schnitzer Properties, LLC, an Oregon limited liability company ("Landlord"), and Healthy Extracts Inc., a Nevada corporation ("Tenant"), dated for reference purposes only, as January 20, 2022 (the "date of this Lease"). BASIC LEASE INFORMATION DESCRIPTION
April 11, 2023	EX-FILING FEES	Filing Fee Table Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Healthy Extracts Inc.
March 31, 2023	EX-10.8	Private Label Agreement with Whitney Johns, Inc. dated October 11, 2021 Noni Discovery Sales and Distr Agree (joint redline 4.9.21) (01839116-5).DOCX PRIVATE LABEL AGREEMENT This Private Label Agreement (this “Agreement”) is entered into on October 11th, 2021 (the “Effective Date”) by and between Healthy Extracts, a Nevada corporation (“HE”) and Whitney Johns, doing business as Whitney Johns, Inc. a S Corp corporation, (“WJ”). HE and WJ shall each be referred to herei
March 31, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extracts, Inc. (
March 23, 2023	EX-10.1	Promissory Note dated March 20, 2023 EX-10.1 2 hyexex10z1.htm PROMISSORY NOTE DATED MARCH 20, 2023 PROMISSORY NOTE $330,000.00March 20, 2023 FOR VALUE RECEIVED, HEALTHY EXTRACTS, INC., a Nevada corporation (hereinafter called the “Borrower” or the “Company”) (Trading Symbol: HYEX), hereby promises to pay to the order of [Ÿ], or registered assigns (the “Holder”), in the form of lawful money of the United States of America, the princip
March 23, 2023	EX-10.2	Common Stock Purchase Warrant dated March 20, 2023 Healthy Extracts Bruce Kaiman Warrant (final) (02114556-2).DOCX HEALTHY EXTRACTS INC. THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“THE ACT”), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMEN
March 23, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2023 HEALTHY EXTRACTS, INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)
February 10, 2023	EX-10.1	Supply Agreement with H&AD S.r.L. dated January 1, 2019, as amended
February 10, 2023	EX-FILING FEES	Filing Fee Table Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Healthy Extracts, Inc.
February 10, 2023	S-1	As filed with the Securities and Exchange Commission on February 9, 2023 As filed with the Securities and Exchange Commission on February 9, 2023 Registration No.
February 10, 2023	EX-10.7	Licensing Agreement with Gelteq Ptd Ltd. EX-10.7 4 hyexex10z7.htm LICENSING AGREEMENT WITH GELTEQ PTD LTD.
February 10, 2023	EX-10.12	Consulting Agreement with Robert Madden Jeremy Hunsicker Form Consult (Draft) (02088618).DOCX HEALTHY EXTRACTS INC CONSULTING SERVICES AGREEMENT This Consulting Services Agreement (this “Agreement”) is entered into on June 1st, 2022 (the “Effective Date”) by and between Healthy Extracts Inc, a Nevada corporation company (the “Company”) and Robert Madden, an individual (the “Consultant”). Each of the Company and the Consultant shall be r
February 10, 2023	EX-14.1	Code of Ethics HE Code of Ethics (02099478).DOCX HEALTHY EXTRACTS, INC. CODE OF BUSINESS CONDUCT AND ETHICS Updated January 2023 Table of Contents 1 HEALTHY EXTRACTS, INC. CODE OF BUSINESS CONDUCT AND ETHICS 3 1.1 INTRODUCTION 3 2 GENERAL COMPLIANCE IS THE RESPONSIBILITY OF ALL EMPLOYEES 3 3 INDIVIDUAL RESPONSIBILITY TO THE COMPANY AND ITS STOCKHOLDERS 4 3.1 General Standards of Conduct 4 3.2 Equal Employment Op
January 27, 2023	EX-10.1	Securities Purchase Agreement dated January 24, 2023 HYEX Walleye SPA (clean 1.24.23) (02097791-2).DOCX SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of January 24, 2023 between Healthy Extracts, Inc., a Nevada corporation (“Company”), and [·] (the “Investor” or the “Purchaser”). WHEREAS, the Investor wishes to purchase from the Company, and the Company wishes to sell and issue to the Investor, (i) a
January 27, 2023	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 24, 2023 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other jurisdiction of incorporation) (Commission F
January 27, 2023	EX-10.3	Common Stock Purchase Warrant dated January 24, 2023 HYEX Walleye Warrant (clean 1.24.23) (02097793-2).DOCX WARRANT NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFE
January 27, 2023	EX-10.2	10% OID Promissory Note dated January 24, 2023 HYEX Walleye Note (clean 1.24.23) (02097792-2).DOCX 10% OID PROMISSORY NOTE NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MA
January 20, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2023 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other (Commission (I.R.S. Employer jurisdiction of
January 20, 2023	EX-10.1	Acquisition Agreement with Hyperion, L.L.C. and Online Publishing & Marketing, LLC dated January 13, 2023 ACQUISITION AGREEMENT by and between Healthy Extracts, Inc., a Nevada corporation, Green Valley Natural Solutions, LLC, a Nevada limited liability company, and Online Publishing & Marketing, LLC, a Nevada limited liability company, on the one hand and Hyperion, L.L.C., a Virginia limited liability company, Online Publishing & Marketing, LLC, a Virginia limited liability company, and the members of
November 8, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy
October 28, 2022	EX-1	CERTIFICATE OF AMENDMENT ARTICLES OF INCORPORATION HEALTHY EXTRACTS INC. CERTIFICATE OF AMENDMENT to ARTICLES OF INCORPORATION of HEALTHY EXTRACTS INC. The undersigned hereby certifies: 1. The name of the Corporation is Healthy Extracts Inc. 2. The articles have been amended as follows: Article 3 is amended and restated as follows: ?Article 3, Authorized Stock: The Corporation has the authority to issue Two Billion Five Hundred Million (2,500,000,000) shares of common
October 28, 2022	DEF 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨Preliminary Information Statement ¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) xDefinitive Information Statement HEALTHY EXTRACTS INC. (Name of Registra
October 17, 2022	PRE 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: xPreliminary Information Statement ?Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) ?Definitive Information Statement HEALTHY EXTRACTS INC. (Name of Registra
October 17, 2022	EX-1	CERTIFICATE OF AMENDMENT ARTICLES OF INCORPORATION HEALTHY EXTRACTS INC. CERTIFICATE OF AMENDMENT to ARTICLES OF INCORPORATION of HEALTHY EXTRACTS INC. The undersigned hereby certifies: 1. The name of the Corporation is Healthy Extracts Inc. 2. The articles have been amended as follows: Article 3 is amended and restated as follows: ?Article 3, Authorized Stock: The Corporation has the authority to issue Two Billion Five Hundred Million (2,500,000,000) shares of common
October 12, 2022	EX-10.1	Loan Agreement with Amazon Capital Services, Inc. entered into on October 7, 2022 LOAN AGREEMENT 1.Promise to Pay. The Business will pay to Amazon Capital Services, Inc. ("we", "us" or "our") the principal, interest, late interest, and any other charges and expenses due to us under this Loan Agreement, including charges and expenses in exercising any of our remedies, which altogether constitutes the "Loan". The Business must make periodic payments of interest and principal acco
October 12, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2022 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other jurisdiction of incorporation) (Commission Fi
August 15, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extr
June 29, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2022 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other (Commission (I.R.S. Employer jurisdiction of in
June 7, 2022	EX-10.1	Securities Purchase Agreement dated May 25, 2022 Healthy Extracts Inc. SECURITIES PURCHASE AGREEMENT $154,000 Convertible Promissory Note SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is entered into on May 25, 2022 (the ?Effective Date?) by and between Healthy Extracts Inc., a Nevada corporation (the ?Company?), and Dan Bishop, an individual (the ?Purchaser?). The Company and the Purchaser shall each be ref
June 7, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2022 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47-
June 7, 2022	EX-10.2	Convertible Promissory Note dated May 25, 2022 NEITHER THIS CONVERTIBLE PROMISSORY NOTE NOR THE SHARES OF COMMON STOCK THAT MAY BE ACQUIRED UPON ITS CONVERSION HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?).
May 16, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Ext
May 4, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2022 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other jurisdiction of incorporation) (Commission File N
May 4, 2022	EX-9.1	Healthy Extracts Investor Presentation
April 1, 2022	EX-10	Lease Agreement dated January 20, 2022 LEASE AGREEMENT (Net) THIS LEASE AGREEMENT (?Lease?) is made between Schnitzer Properties, LLC, an Oregon limited liability company (?Landlord?), and Healthy Extracts Inc.
April 1, 2022	NT 10-K	FORM 12b-25 NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-55572 Washington, D.
April 1, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extracts Inc. (E
March 2, 2022	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2022 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number
March 2, 2022	EX-10.1	Common Stock Purchase Warrant dated February 10, 2022 HEALTHY EXTRACTS INC. THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (?THE ACT?), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTEN
March 2, 2022	EX-10.2	Promissory Note dated February 22, 2022 PROMISSORY NOTE $200,000.00 February 22th, 2022 FOR VALUE RECEIVED, HEALTHY EXTRACTS INC., a Nevada corporation (hereinafter called the ?Borrower? or the ?Company?) (Trading Symbol: HYEX), hereby promises to pay to the order of Bruce Kaiman, or registered assigns (the ?Holder?), in the form of lawful money of the United States of America, the principal sum of $200,000.00, which amount is the $180,
January 7, 2022	DEF 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 DEF 14C 1 hyex-20220107def14c.htm DEF 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) x Definitive Information Stat
December 23, 2021	PRE 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) o Definitive Information Statement HEALTHY EXTRACTS INC. (Name of Regis
November 15, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy
September 8, 2021	CORRESP	September 8, 2021 September 8, 2021 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.
September 3, 2021	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FIRST AMENDED FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FIRST AMENDED FORM 10-Q/A (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55
September 3, 2021	EX1A-11 CONSENT	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO September 3 , 2021
September 3, 2021	PART II AND III	U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off
September 3, 2021	EX1A-12 OPN CNSL	September 3, 2021 September 3, 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connection with the proposed offering by the Company
August 25, 2021	EX1A-11 CONSENT	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO August 24 , 2021
August 25, 2021	EX1A-12 OPN CNSL	August 24, 2021 August 24, 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connection with the proposed offering by the Company of
August 25, 2021	PART II AND III	U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off
August 16, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extr
August 13, 2021	EX1A-12 OPN CNSL	August 13, 2021 August 13, 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connection with the proposed offering by the Company of
August 13, 2021	EX1A-11 CONSENT	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO August 13 , 2021
August 13, 2021	PART II AND III	U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off
August 6, 2021	EX1A-4 SUBS AGMT	HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC. EX1A-4 SUBS AGMT 3 grck-1aex4z1.htm EX1A-4 SUBS AGMT HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC. Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Ladies and Gentlemen: 1. Subscription. The person named on the signature page of this subscription agreement (the “Purchaser”) (this “Subscr
August 6, 2021	EX1A-12 OPN CNSL	August 6, 2021 August 6, 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connection with the proposed offering by the Company of
August 6, 2021	PART II AND III	U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off
August 6, 2021	EX1A-11 CONSENT	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO August 6 , 2021
August 6, 2021	CORRESP	August 6, 2021 August 6, 2021 United States Securities and Exchange Commission Washington, D.C. 20549 Re: Healthy Extracts Inc. Amendment No. 3 to Offering Statement on Form 1-A Filed August 6, 2021 File No. 024-11481 In response to the comment letter issued by the Commission on July 26, 2021, the issuer has the following responses. Amendment No. 3 to Offering Statement on Form 1-A Plan of Distribution, page 15
August 3, 2021	EX-10.2	Independent Contractor Agreement by and between the Company and Kevin “Duke” Pitts, dated October 1, 2019
August 3, 2021	10-Q/A	SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No.1 (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-
August 3, 2021	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A Amendment No.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A Amendment No.1 ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy
August 3, 2021	EX-3.2	Certificate of Amendment of Articles of Incorporation
July 29, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2021 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47
July 29, 2021	EX-99	Healthy Extracts Investor Presentation dated July 29, 2021
July 9, 2021	EX1A-11 CONSENT	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO July 7 , 2021
July 9, 2021	EX1A-12 OPN CNSL	July 7, 2021 July 7, 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connection with the proposed offering by the Company of up
July 9, 2021	CORRESP	July 7, 2021 July 7, 2021 United States Securities and Exchange Commission Washington, D.C. 20549 Re: Healthy Extracts Inc. Amendment No. 2 to Offering Statement on Form 1-A Filed June 7, 2021 File No. 024-11481 In response to the comment letter issued by the Commission on June 24, 2021, the issuer has the following responses. Amendment No. 2 to Offering Statement on Form 1-A Plan of Distribution, page 15 1. I
July 9, 2021	EX1A-4 SUBS AGMT	HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC. HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC. Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Ladies and Gentlemen: 1. Subscription. The person named on the signature page of this subscription agreement (the “Purchaser”) (this “Subscription Agreement”), intending to be legally bound, he
July 9, 2021	PART II AND III	U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off
June 7, 2021	CORRESP	June 1, 2021 June 1, 2021 United States Securities and Exchange Commission Washington, D.C. 20549 Re: Healthy Extracts Inc. Amendment No. 1 to Offering Statement on Form 1-A Filed May 7, 2021 File No. 024-11481 In response to the comment letter issued by the Commission on May 20, 2021, the issuer has the following responses. Amendment No. 1 to Offering Statement on Form 1-A Business, page 25 1. We note your re
June 7, 2021	PART II AND III	U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off
June 7, 2021	EX1A-4 SUBS AGMT	HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC. HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC. Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Ladies and Gentlemen: 1. Subscription. The person named on the signature page of this subscription agreement (the “Purchaser”) (this “Subscription Agreement”), intending to be legally bound, he
June 7, 2021	EX1A-11 CONSENT	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO June 1 , 2021
June 7, 2021	EX1A-12 OPN CNSL	June 1, 2021 June 1, 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connection with the proposed offering by the Company of up
May 14, 2021	10-Q	SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Ext
May 7, 2021	CORRESP	May 3, 2021 May 3, 2021 United States Securities and Exchange Commission Washington, D.C. 20549 Re: Healthy Extracts Inc. Offering Statement on Form 1-A Filed March 11, 2021 File No. 024-11481 In response to the comment letter issued by the Commission on April 7, 2021, the issuer has the following responses. Form 1-A Cover Page 1. Please disclose that your common stock is traded on the OTCQB and disclose the
May 7, 2021	EX1A-6 MAT CTRCT	Independent Contractor Agreement by and between the Company and Kevin “Duke” Pitts, dated October 1, 2019
May 7, 2021	EX1A-4 SUBS AGMT	HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC. HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC. Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Ladies and Gentlemen: 1. Subscription. The person named on the signature page of this subscription agreement (the “Purchaser”) (this “Subscription Agreement”), intending to be legally bound, he
May 7, 2021	EX1A-6 MAT CTRCT	EX1A-6 MAT CTRCT
May 7, 2021	EX1A-11 CONSENT	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO April 30, 2021
May 7, 2021	PART II AND III	U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off
May 7, 2021	EX1A-12 OPN CNSL	[Ÿ], 2021 EX1A-12 OPN CNSL 8 grck-1aex12z1.htm EX1A-12 OPN CNSL [Ÿ], 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connect
March 19, 2021	EX-10	Promissory Note dated March 18, 2021 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
March 19, 2021	EX-10	Securities Purchase Agreement dated March 18, 2021 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of March 18, 2021, by and between HEALTHY EXTRACTS INC.
March 19, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2021 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 4
March 11, 2021	PART II AND III	- PART II AND III U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off
February 19, 2021	10-K	Annual Report - 10-K 10-K 1 grck-2020123110k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 0
February 19, 2021	EX-10.2	Employment Agreement by and between the Company and Kevin “Duke” Pitts, dated September 28, 2018
February 19, 2021	EX-3.2	Certificate of Amendment of Articles of Incorporation
February 12, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2021 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)
October 29, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Grey Cl
October 19, 2020	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2020 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)
October 5, 2020	DEF 14C	- DEF 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) [ X ] Definitive Information Statement GREY CLOAK TECH INC. (Name o
October 1, 2020	EX-4	Grey Cloak Tech Inc. 2020 Omnibus Stock Grant and Option Plan (the “Plan”) GREY CLOAK TECH INC. 2020 OMNIBUS STOCK GRANT AND OPTION PLAN -1- TABLE OF CONTENTS Page SECTION 1. PURPOSE 1 SECTION 2. DEFINITIONS 1 (a) “Award” 1 (b) “Board of Directors” 1 (c) “Change in Control” 1 (d) “Code” 1 (e) “Committee” 1 (f) “Common-Law Employee” 2 (g) “Company” 2 (h) “Employee” 2 (i) “Exchange Act” 2 (j) “Exercise Price” 2 (k) “Fair Market Value” 2 (l) “Incentive Stock Option” or “ISO
October 1, 2020	S-8	- S-8 S-8 1 grck-20201001s8.htm S-8 As filed with the Securities and Exchange Commission on October 1, 2020 Registration No. 333- U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 Grey Cloak Tech Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation or Organization) 27
October 1, 2020	EX-4	Form of Statutory Stock Option Agreement relating to options granted under the Plan THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS OF FEDERAL AND STATE SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION AND QUALIFICATION UNDER FEDERAL AND STATE SECURITIES LAWS IS NOT REQUIRED.
October 1, 2020	EX-4	Form of Non-Statutory Stock Option Agreement relating to options granted under the Plan THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS OF FEDERAL AND STATE SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION AND QUALIFICATION UNDER FEDERAL AND STATE SECURITIES LAWS IS NOT REQUIRED.
September 22, 2020	PRE 14C	- PRE 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ X ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) [ ] Definitive Information Statement GREY CLOAK TECH INC. (Name o
September 15, 2020	10-Q	Quarterly Report - 10-Q 10-Q 1 grck-2020063010q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission f
August 14, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Grey Cloak
August 10, 2020	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Grey Cloak Tech Inc. (Ex
June 1, 2020	10-Q	Quarterly Report - FORM 10-Q FOR PERIOD ENDING SEPT 30, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 GREY CL
May 29, 2020	10-Q	Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 GREY CLOAK T
May 28, 2020	EX-10.1	Share Exchange Agreement dated February 4, 2019 by and among Grey Cloak Tech Inc., BergaMet NA, LLC, and the Members of BergaMet SHARE EXCHANGE AGREEMENT dated as of February 4, 2019 by and among Grey Cloak Tech Inc.
May 28, 2020	EX-10.3	Form of Preferred Stock Conversion Agreement PREFERRED STOCK CONVERSION AGREEMENT This Preferred Stock Conversion Agreement (this “Agreement”) is entered into on [•], 2019 by and between Grey Cloak Tech Inc.
May 28, 2020	EX-10.2	Form of Note Satisfaction Agreement NOTE SATISFACTION AGREEMENT This Note Satisfaction Agreement (this “Agreement”) is entered into on [Ÿ], 2019 (the “Effective Date”) by and between Grey Cloak Tech Inc.
May 28, 2020	10-Q	Quarterly Report - FORM 10-Q FOR PERIOD ENDING MARCH 31, 2020 10-Q 1 grck-2019033110q.htm FORM 10-Q FOR PERIOD ENDING MARCH 31, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the t
April 17, 2020	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2020 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47
April 8, 2020	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2020 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47-
April 8, 2020	EX-10.1	Share Exchange Agreement with Ultimate Brain Nutrients, LLC and its members SHARE EXCHANGE AGREEMENT dated as of April , 2020 by and among Grey Cloak Tech Inc.
April 7, 2020	8-K	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2020 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47-
April 7, 2020	EX-16.1	Letter from Prager Metis CPAs LLC dated April 6, 2020 April 6, 2020 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 We have read the statements made by Grey Cloak Tech, Inc. under Item 4.01 of its Form 8-K dated April 7, 2020. We agree with the statements set forth in Item 4.01 insofar as the relate our Firm. We have no basis to agree or disagree with other statements made by the registrant contained in Item 4.01. Very trul
April 1, 2020	EX-10	Share Exchange Agreement dated February 4, 2019 by and among Grey Cloak Tech Inc., BergaMet NA, LLC, and the Members of BergaMet SHARE EXCHANGE AGREEMENT dated as of February 4, 2019 by and among Grey Cloak Tech Inc.
April 1, 2020	10-K	GRCK / GREY CLOAK TECH INC 10-K - Annual Report - FORM 10-K FOR PERIOD ENDING DECEMBER 31, 2018 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Grey Cloak Tech Inc. (Ex
October 4, 2019	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2019 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 4
September 27, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2019 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number
August 27, 2019	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2019 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47-
April 25, 2019	EX-10.2	Unsecured Promissory Note, dated February 4, 2019, issued to William Bossung PROMISSORY NOTE $61,875.91 February 4 , 2019 FOR VALUE RECEIVED, Grey Cloak Tech Inc., a Nevada corporation (“Borrower”), promises to pay to William Bossung (“Lender”) on or before February 4, 2020 (the “Maturity Date”) or earlier as provided herein, at any place designated by Lender, the principal amount of $61,875.91 (the “Principal Amount”), constituting all outstanding amounts previously advan
April 25, 2019	EX-10.1	Unsecured Convertible Promissory Note, dated September 30, 2018, issued to William Bossung THIS CONVERTIBLE PROMISSORY NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
April 25, 2019	10-Q	GRCK / GREY CLOAK TECH INC 10-Q (Quarterly Report) FORM 10-Q FOR PERIOD ENDING SEPTEMBER 30, 2018 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 333-202542 GREY C
February 8, 2019	EX-99.1	Grey Cloak Tech Inc. Completes Acquisition of BergaMet NA, LLC Grey Cloak Tech Inc. Completes Acquisition of BergaMet NA, LLC Las Vegas, NV (February 7, 2019)- via New Media Wire -Grey Cloak Tech Inc (OTC: GRCK) is pleased to announce the completion of its acquisition of BergaMet NA, LLC. BergaMet is now a wholly-owned subsidiary of Grey Cloak Tech Inc. BergaMet imports, manufactures and distributes a proprietary line of products derived from the rare citrus
February 8, 2019	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2019 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)
November 14, 2018	NT 10-Q	GRCK / GREY CLOAK TECH INC NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-55572 Washington, D.
October 29, 2018	8-K	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2018 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)
October 29, 2018	EX-16.1	Letter to Securities and Exchange Commission from Paritz & Company, P.A., dated October 29, 2018. October 29, 2018 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 We have read the statements made by Grey Cloak Tech, Inc. under Item 4.01 of its Form 8-K dated October 29, 2018. We agree with the statements concerning our Firm in such Form 8-K. Very truly yours /s/Paritz & Company, PA
October 4, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2018 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number
September 26, 2018	SC 13G	GRCK / GREY CLOAK TECH INC / Gs Capital Partners, Llc - SCHEDULE 13G Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Grey Cloak Tech Inc (Name of Issuer) Common Stock (Title of Class of Securities) 397845207 (CUSIP Number) September 18, 2018 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule
September 21, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 17, 2018 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number
September 11, 2018	10-Q	GRCK / GREY CLOAK TECH INC FORM 10-Q FOR PERIOD ENDED JUNE 30, 2018 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 GREY CLOAK T
August 14, 2018	NT 10-Q	GRCK / GREY CLOAK TECH INC NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-55572 Washington, D.
July 13, 2018	10-Q/A	GRCK / GREY CLOAK TECH INC FORM 10-Q FOR PERIOD ENDED MARCH 31, 2018 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 333
July 12, 2018	10-Q	GRCK / GREY CLOAK TECH INC FORM 10-Q FOR PERIOD ENDED MARCH 31, 2018 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 333-202542 GREY CLOAK
June 8, 2018	EX-10.32	Employment Agreement by and between the Company and William Bossung, dated October 17, 2017 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is entered into effective October 17, 2017 (the “Effective Date”) by and between Grey Cloak Tech Inc.
June 8, 2018	EX-10.37	Convertible Promissory Note, dated October 27, 2017, issued to DT Growth Partners LLC NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
June 8, 2018	EX-10.38	Convertible Promissory Note, dated October 31, 2017, issued to Power Up Lending Group Ltd. NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
June 8, 2018	EX-10.36	Convertible Promissory Note, dated October 17, 2017, issued to Fred Covely EX-10.36 7 grck-2017123110kex10z36.htm EXHIBIT 10.36 THIS CONVERTIBLE PROMISSORY NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. NO SALE OR DISPOSITION MAY BE EFFECTED EXCEPT IN COMPLIANCE WITH RULE 144 UNDER SAID ACT OR AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL FOR THE HOLDER. GREY CLOAK TECH INC. CONVERTIBLE PROMISSORY NOTE $30,000 Oc
June 8, 2018	EX-10.33	Second Amendment to the Securities Purchase Agreement by and between the Company and Crown Bridge Partners, LLC, dated December 28, 2017 SECOND AMENDMENT TO SECURITIES PURCHASE AGREEMENT This Second Amendment to the Securities Purchase Agreement (the “Amendment”) is entered into and effective on December 28, 2017 (the “Effective Date”), by and between Grey Cloak Tech, Inc.
June 8, 2018	EX-10.40	Convertible Promissory Note, dated December 11, 2017, issued to Auctus Fund, LLC EX-10.40 11 grck-2017123110kex10z40.htm EXHIBIT 10.40 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A)
June 8, 2018	EX-10.35	Convertible Promissory Note, dated October 4, 2017, issued to Adar Bays, LLC THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT”) US $50,000.
June 8, 2018	EX-10.34	First Amendment to the Convertible Promissory Note issued to Crown Bridge Partners, LLC, dated December 28, 2017 FIRST AMENDMENT TO CONVERTIBLE PROMISSORY NOTE This First Amendment to the Convertible Promissory Note (the “Amendment”) is entered into on December 28, 2017 by and between Grey Cloak Tech, Inc.
June 8, 2018	EX-10.39	Convertible Promissory Note, dated November 2, 2017, issued to Oakmore Opportunity Fund I LP NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
June 8, 2018	10-K	GRCK / GREY CLOAK TECH INC FORM 10-K FOR PERIOD ENDED DECEMBER 31, 2017 (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Grey Cloak Tech Inc. (Ex
June 8, 2018	EX-10.31	Employment Agreement by and between the Company and Patrick Stiles, dated October 17, 2017 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is entered into effective October 17, 2017 (the “Effective Date”) by and between Grey Cloak Tech Inc.
April 2, 2018	NT 10-K	GRCK / GREY CLOAK TECH INC NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-55572 Washington, D.
March 29, 2018	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2018 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47
February 28, 2018	DEF 14A	GRCK / GREY CLOAK TECH INC DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ X ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [
February 16, 2018	CORRESP	GRCK / GREY CLOAK TECH INC CORRESP February 16, 2018 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.
February 6, 2018	PRE 14A	GRCK / GREY CLOAK TECH INC PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ X ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ X ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
January 4, 2018	8-K	GRCK / GREY CLOAK TECH INC CURRENT REPORT (Current Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)
January 4, 2018	EX-3.1	Certificate of Amendment to the Articles of Incorporation CERTIFICATE OF AMENDMENT to ARTICLES OF INCORPORATION of GREY CLOAK TECH, INC. The undersigned hereby certifies: 1. The name of the Corporation is Grey Cloak Tech, Inc. 2. The articles have been amended as follows: Article 3 is amended and restated as follows: ?Article 3, Authorized Stock: The corporation has the authority to issue One Billion (1,000,000,000) shares of common stock, par value $0.0
December 29, 2017	8-K	GRCK / GREY CLOAK TECH INC CURRENT REPORT (Current Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55572 (Commission File Number)
November 20, 2017	EX-99.1	Grey Cloak Tech, Inc. Announces Purchase of CBD.co Domain and Plans to Build a CBD Marketplace Grey Cloak Tech, Inc. Announces Purchase of CBD.co Domain and Plans to Build a CBD Marketplace LAS VEGAS, NV ? GRCK, (Marketwired) ? 11/15/17 ? Grey Cloak Tech Inc. (OTCQB: GRCK) today announces its purchase of the domain CBD.co. This announcement is made just as the Marijuana Business Conference (MJ BizCon) in Las Vegas is underway. Grey Cloak?s vision for CBD.co is to make it a media destination
November 20, 2017	8-K	GRCK / GREY CLOAK TECH INC CURRENT REPORT (Current Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)
November 15, 2017	DEF 14A	GRCK / GREY CLOAK TECH INC DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ X ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [
November 15, 2017	NT 10-Q	GRCK / GREY CLOAK TECH INC NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-55572 Washington, D.
November 15, 2017	10-Q	GRCK / GREY CLOAK TECH INC FORM 10-Q FOR PERIOD ENDED SEPTEMBER 30, 2017 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 GREY CL
November 3, 2017	PRE 14A	GRCK / GREY CLOAK TECH INC PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ X ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ X ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
October 23, 2017	EX-99.1	Grey Cloak Tech Completes Acquisition of Eqova Life Sciences Grey Cloak Tech Completes Acquisition of Eqova Life Sciences LAS VEGAS, NV - (Marketwired) - 10/23/17 - Grey Cloak Tech Inc.
October 23, 2017	EX-3.1	Amended and Restated Certificate of Designation of the Series A Convertible Preferred Stock, dated October 16, 2017. AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF THE RIGHTS, PREFERENCES, PRIVILEGES AND RESTRICTIONS, WHICH HAVE NOT BEEN SET FORTH IN THE CERTIFICATE OF INCORPORATION OR IN ANY AMENDMENT THERETO, OF THE SERIES A CONVERTIBLE PREFERRED STOCK OF GREY CLOAK TECH INC.
October 23, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)
October 4, 2017	8-K	GREY CLOAK TECH CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 18, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number
October 4, 2017	EX-99.1	Grey Cloak Tech Announces Letter of Intent to Acquire Eqova Life Sciences Grey Cloak Tech Announces Letter of Intent to Acquire Eqova Life Sciences Grey Cloak Tech Inc.
September 29, 2017	SC 13G	GRCK / GREY CLOAK TECH INC / Oakmore Opportunity Fund I LP - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* GREY CLOAK TECH, INC. (Name of Issuer) Shares of Common Stock (Title of Class of Securities) 397845108 (CUSIP Number) September 26, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t
August 18, 2017	10-Q	GRCK / GREY CLOAK TECH INC FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2017 (Quarterly Report) 10-Q 1 grck-2017063010q.htm FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the
August 14, 2017	NT 10-Q	GREY CLOAK TECH NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-55572 Washington, D.
May 25, 2017	EX-10.2	Promissory Note issued by ShareRails, LLC to the Company, dated May 19, 2017 Exhibit 10.2 CONVERTIBLE PROMISSORY NOTE $100,000 May 19, 2017 FOR VALUE RECEIVED, ShareRails, LLC, a Delaware limited liability company, its assigns and successors (the ?Borrower?), hereby promises to pay to the order of Grey Cloak Tech Inc., a Nevada corporation (the ?Lender?), or assigns, in immediately available funds, the principal sum of One Hundred Thousand Dollars ($100,000). The principal
May 25, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47-2
May 25, 2017	EX-10.1	Termination Agreement and Acknowledgement by and among the Company, ShareRails, LLC, Joseph Nejman, Dmitry Chourpo, Joseph Nejman, in his capacity as the “Selling Members’ Representative,” William Bossung, Fred Covely, Dimicho Pty. Ltd. and Covely Information Systems, dated May 19, 2017 Exhibit 10.1 TERMINATION AGREEMENT AND ACKNOWLEDGEMENT This Termination Agreement and Acknowledgement (?Termination Agreement?) is entered into on May 19, 2017 by and among Grey Cloak Tech Inc., a Nevada corporation (the ?Buyer?), ShareRails, LLC, a Delaware limited liability company (the ?Company?), Joseph Nejman, an individual (?Nejman?), Dmitry Chourpo, an individual (?Chourpo?), Joseph Nejman,
May 25, 2017	EX-10.4	Development Services Agreement by and between the Company and Covely Information Systems, dated March 31, 2017 Development Services Agreement This Development Services Agreement (this ?Agreement?) is entered into effective March 31, 2017 (the ?Effective Date?) by and between Grey Cloak Tech Inc.
May 25, 2017	EX-10.5	Development Services Agreement by and between the Company and Dimicho Pty. Ltd., dated March 31, 2017 Development Services Agreement This Development Services Agreement (this ?Agreement?) is entered into effective April 1, 2017 (the ?Effective Date?) by and between Grey Cloak Tech Inc.
May 25, 2017	EX-10.2	Employment Agreement by and between the Company and William Bossung, dated March 31, 2017 EMPLOYMENT AGREEMENT This Employment Agreement (this ?Agreement?) is entered into effective March 31, 2017 (the ?Effective Date?) by and between Grey Cloak Tech Inc.
May 25, 2017	EX-10.1	Share Exchange Agreement by and among the Company, ShareRails, LLC, Joseph Nejman, Dmitry Chourpo and Joseph Nejman, in his capacity as the Selling Members’ Representative, dated March 31, 2017 SHARE EXCHANGE AGREEMENT dated as of March 31, 2017 by and among Grey Cloak Tech Inc.
May 25, 2017	10-Q	GREY CLOAK TECH FORM 10-Q FOR PERIOD ENDED MARCH 31, 2017 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 333-202542 GREY CLOAK
May 25, 2017	EX-10.3	Employment Agreement by and between the Company and Joseph Nejman, dated March 31, 2017 EMPLOYMENT AGREEMENT This Employment Agreement (this ?Agreement?) is entered into effective March 31, 2017 (the ?Effective Date?) by and between Grey Cloak Tech Inc.
May 25, 2017	SC 13D	GRCK / GREY CLOAK TECH INC / Nejman Joseph - SC13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Grey Cloak Tech Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 397845108 (CUSIP Number) Brian A. Lebrecht c/o Clyde Snow & Sessions, P.C. 201 South Main Street, Suite 1300 Salt Lake City, UT 84111 (Name, Addr
May 15, 2017	NT 10-Q	GREY CLOAK TECH NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 333-201288 Washington, D.
May 1, 2017	EX-99.1	Shareholders Agreement dated March 31, 2017. SHAREHOLDERS AGREEMENT This Shareholders Agreement (this “Agreement”) is entered into on March 31, 2017 (the “Effective Date”) by and between Grey Cloak Tech Inc.
May 1, 2017	SC 13D	GRCK / GREY CLOAK TECH INC / Nejman Joseph - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Grey Cloak Tech Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 397845108 (CUSIP Number) Brian A. Lebrecht c/o Clyde Snow & Sessions, P.C. 201 South Main Street, Suite 1300 Salt Lake City, UT 84111 (Name, Addr
April 17, 2017	EX-10.22	Convertible Promissory Note dated February 24, 2017 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION NOR THE SECURITIES COMMISSION OF ANY STATE.
April 17, 2017	10-K	GREY CLOAK TECH FORM 10-K FOR PERIOD ENDED DECEMBER 31, 2016 (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Grey Cloak Tech Inc. (Ex
April 17, 2017	EX-10.17	Convertible Promissory Note dated December 9, 2016 DEBT PURCHASE AND ASSIGNMENT AGREEMENT THIS DEBT PURCHASE AND ASSIGNMENT AGREEMENT (this "Agreement" ), is entered into on December 7, 2016, by and between Village Partners LLC (the "Assignor") and Coronado Ventures Number One, LLC (the "Assignee") (the Assignor and Assignee are collectively referred to as the "Parties" herein).
April 17, 2017	EX-10.21	Convertible Promissory Note dated February 24, 2017 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION NOR THE SECURITIES COMMISSION OF ANY STATE.
April 17, 2017	EX-10.16	Convertible Promissory Note dated November 17, 2016 NEITHER THIS NOTE NOR THE SECURITIES THAT MAY BE ISSUED BY THE COMPANY UPON CONVERSION HEREOF (COLLECTIVELY, THE ?SECURITIES?) HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?1933 ACT?), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION.
April 17, 2017	EX-10.20	Convertible Promissory Note dated January 23, 2017 Convertible Promissory Note dated January 23, 2017 - 1 - Convertible Promissory Note dated January 23, 2017 - 2 - Convertible Promissory Note dated January 23, 2017 - 3 - Convertible Promissory Note dated January 23, 2017 - 4 - Convertible Promissory Note dated January 23, 2017 - 5 - Convertible Promissory Note dated January 23, 2017 - 6 - Convertible Promissory Note dated January 23, 2017 - 7 - C
April 17, 2017	EX-10.18	Convertible Promissory Note dated January 23, 2017 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
April 17, 2017	EX-10.23	Convertible Promissory Note dated March 1, 2017 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
April 17, 2017	EX-10.19	Convertible Promissory Note dated January 23, 2017 Convertible Promissory Note dated January 23, 2017 - 1 - Convertible Promissory Note dated January 23, 2017 - 2 - Convertible Promissory Note dated January 23, 2017 - 3 - Convertible Promissory Note dated January 23, 2017 - 4 - Convertible Promissory Note dated January 23, 2017 - 5 - Convertible Promissory Note dated January 23, 2017 - 6 - Convertible Promissory Note dated January 23, 2017 - 7 - C
April 17, 2017	EX-10.29	Convertible Promissory Note dated March 10, 2017 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
April 17, 2017	EX-10.24	Convertible Promissory Note dated March 7, 2017 Convertible Promissory Note dated March 7, 2017 -1- Convertible Promissory Note dated March 7, 2017 -2- Convertible Promissory Note dated March 7, 2017 -3- Convertible Promissory Note dated March 7, 2017 -4- Convertible Promissory Note dated March 7, 2017 -5- Convertible Promissory Note dated March 7, 2017 -6- Convertible Promissory Note dated March 7, 2017 -7- Convertible Promissory Note dated Ma
April 17, 2017	EX-10.27	Convertible Promissory Note dated March 10, 2017 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
April 17, 2017	EX-10.26	Convertible Promissory Note dated March 10, 2017 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
April 17, 2017	EX-10.28	Convertible Promissory Note dated March 10, 2017 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
April 17, 2017	EX-10.25	Convertible Promissory Note dated March 10, 2017 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
April 17, 2017	EX-10.30	Convertible Promissory Note dated March 10, 2017 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
April 6, 2017	EX-3.1	Certificate of Designation of the Series A Convertible Preferred Stock CERTIFICATE OF DESIGNATION OF THE RIGHTS, PREFERENCES, PRIVILEGES AND RESTRICTIONS, WHICH HAVE NOT BEEN SET FORTH IN THE CERTIFICATE OF INCORPORATION OR IN ANY AMENDMENT THERETO, OF THE SERIES A CONVERTIBLE PREFERRED STOCK OF GREY CLOAK TECH INC.
April 6, 2017	8-K	GREY CLOAK TECH CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47
March 30, 2017	NT 10-K	GREY CLOAK TECH NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-55572 CUSIP NUMBER: 889043105 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Re
February 27, 2017	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)
February 27, 2017	EX-3.1	Certificate of Amendment to the Articles of Incorporation, dated February 24, 2017 CERTIFICATE OF AMENDMENT to ARTICLES OF INCORPORATION of GREY CLOAK TECH, INC. The undersigned hereby certifies: 1. The name of the Corporation is Grey Cloak Tech, Inc. 2. The articles have been amended as follows: ?Article 3, Authorized Stock: The corporation has the authority to issue Five Hundred Million (500,000,000) shares of common stock, par value $0.001 per share, and Seventy Five Million
February 1, 2017	DEF 14A	GREY CLOAK TECH DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ X ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [
January 21, 2017	PRE 14A	GREY CLOAK TECH PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ X ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ X ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
January 4, 2017	CORRESP	GREY CLOAK TECH ESP January 3, 2017 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.
December 23, 2016	PRE 14C	GREY CLOAK TECH PRE 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ X ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) [ ] Definitive Information Statement GREY CLOAK TECH, INC. (Name
November 22, 2016	EX-10.4	Convertible Promissory Note dated September 7, 2016 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

HYEX / Healthy Extracts Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)